Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy

By Kang Cheol-In  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 7, 2013-07 ,pp. : 519-525

Informa Healthcare

Access to resources Recommend Favorite

Cessation of Contact Precautions for Extended-Spectrum Beta-Lactamase (ESBL)–Producing Escherichia coli Seems to be Safe in a Nonepidemic Setting

By  

Infection Control & Hospital Epidemiology, Vol. 38, Iss. 11, 2017-09 ,pp. : 1379-1381

Cambridge University Press

Access to resources Recommend Favorite

Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli

By Alsterlund Rolf   Axelsson Carolina   Olsson-Liljequist Barbro  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 1, 2012-01 ,pp. : 51-54

Informa Healthcare

Access to resources Recommend Favorite

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea

By Tham Johan   Odenholt Inga   Walder Mats   Brolund Alma   Ahl Jonas   Melander Eva  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 4, 2010-03 ,pp. : 275-280

Informa Healthcare

Access to resources Recommend Favorite

Comparison of community‐onset healthcare‐associated and hospital‐acquired urinary infections caused by extended‐spectrum beta‐lactamase‐producing Escherichia coli and antimicrobial activities

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 766-770

John Wiley & Sons Inc

Access to resources Recommend Favorite